-
News | 2022.07.09
Conversation: capacity building to prepare for the future
Institut Pasteur Senior Executive Scientific Vice-President Christophe d'Enfert provides a brief, cross-disciplinary overview of 2021 covering capacity building, enhanced partnerships and future technologies.
-
News | 2022.08.05
Our own RNA triggers an immune response to viral infections
An immune receptor normally known for identifying viral RNA is also capable of binding to cellular RNA to induce immune defenses. This mechanism could trigger immunity against viruses before they become detectable.
-
News | 2024.09.18
Whooping cough: how do we explain its resurgence in 2024 in France?
In a study coordinated by the Institut Pasteur, scientists describe the dynamics of the whooping cough epidemic in 2024 in France, the worst in 25 years. The scientists also sequenced the genome of almost 70 bacterial isolates collected during the outbreak from January to mid-2024. These analyses allowed them to put forward several theories explaining the current resurgence in circulation of the...
-
News | 2025.08.27
Discover the Pasteur Institute's major discoveries for 2024
A gene therapy trial for childhood deafness. A malaria vaccine. Microbiome gene editing. Cancer immunotherapy. A key gene in embryonic development. Effective treatment for bronchiolitis. Indian Ocean temperatures for anticipating outbreaks... Here is an excerpt from our discoveries for 2024. You can also download the poster in PDF format at the bottom of the page.
-
News | 2026.03.08
Mathilda: The Music Video Giving a Voice Back to Women in Science
On the occasion of International Women’s Rights Day on March 8, 2026, Yaëlle Wormser, a PhD student in microbiology at Université Paris Cité and the Institut Pasteur—also known by her stage name Lady Pipette—is releasing “Mathilda,” an engaged music video centered on the Matilda effect. At the intersection of science and creative expression, this project highlights the invisibilization of women...
-
Portrait | 2026.03.30
Guillemette Masse-Ranson: the scientist breaking down barriers within vaccine research
Guillemette Masse-Ranson, Deputy Director of the Institut Pasteur Vaccinology and Immunotherapy Center, combines industry experience with a passion for academic research. Her ambition is to revolutionize vaccine development by breaking down silos between disciplines, speeding up the transition from lab to clinical practice, and connecting the Institut Pasteur's scientists to international...
-
Document de presse | 2022.07.13
Light shed on SARS-CoV-2 replication in bat cells
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
-
Portrait | 2022.12.13
Pierre-Marie Lledo: a neuro-optimist in work and in life
Perception, emotions, behavior, decision-making, memory, good mental health, depression – these are some of the research topics that interest Pierre-Marie Lledo. With his team of biologists, physicians, mathematicians, biophysicists and biochemists, he is working to uncover some of the most intimate mechanisms in the brain.
-
Document de presse | 2023.01.13
Using paleogenomics to elucidate 10,000 years of immune system evolution
Scientists from the Institut Pasteur, Université Paris Cité, the CNRS and the Collège de France have used paleogenomics to trace 10,000 years of human immune system evolution. They analyzed the genomes of more than 2,800 individuals who lived in Europe over the past ten millennia. They were able to date the increase in frequency of most of the mutations that are advantageous in defending against...
-
Document de presse | 2023.10.25
New discovery concerning receptors used by coronaviruses to enter human cells
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the question of why one coronavirus affects humans more severely than another. Scientists at the Institut Pasteur, Université Paris Cité and the VRI have now provided part of the...
